Search

Depression and MS: Diagnosing and Treating

Depression and MS: Diagnosing and TreatingAnthony Feinstein, MPhil, PhD, FRCP RELEASE DATE: May 27, 2020 EXPIRATION DATE: May 31, 2021 TIME TO COMPLETE THE ACTIVITY: 1 hour TARGET AUDIENCEThis activity has been designed to meet the educational needs of physicians, advanced practice clinicians, nursing professionals, pharmacists, psychologists, social workers, rehabilitation specialists, researchers, advocates, and other …

Comorbidities and MS: Critical Thinking About DMTs and Vaccines

Comorbidities and MS: Critical Thinking About DMTs and VaccinesPatricia Melville, NP-C, MSCN, and Marijean Buhse, PhD, NP-C, MSCN RELEASE DATE: May 26, 2020 EXPIRATION DATE: May 31, 2021 TIME TO COMPLETE THE ACTIVITY: 1 hour TARGET AUDIENCEThis activity has been designed to meet the educational needs of physicians, advanced practice clinicians, nursing professionals, pharmacists, psychologists, …

Whitaker Lecture: CNS Immune Responses that Underlie Progressive MS: Future Challenges in the COVID-19 Era

Whitaker Lecture: CNS Immune Responses that Underlie Progressive MS: Future Challenges in the COVID-19 EraPeter Calabresi, MD RELEASE DATE: May 26, 2020 EXPIRATION DATE: May 31, 2021 TIME TO COMPLETE THE ACTIVITY: 1 hour TARGET AUDIENCEThis activity has been designed to meet the educational needs of physicians, advanced practice clinicians, nursing professionals, pharmacists, psychologists, social …

Science, Art, and Practice of Behavioral Medicine

Science, Art, and Practice of Behavioral MedicineAmy Sullivan, PsyD, ABPP RELEASE DATE: May 26, 2020 EXPIRATION DATE: May 31, 2021 TIME TO COMPLETE THE ACTIVITY: 1 hour TARGET AUDIENCEThis activity has been designed to meet the educational needs of physicians, advanced practice clinicians, nursing professionals, pharmacists, psychologists, social workers, rehabilitation specialists, researchers, advocates, and other …

Neuromyelitis Optica Spectrum Disorders: Emerging Treatment Options

Neuromyelitis Optica Spectrum Disorders: Emerging Treatment OptionsBrian Weinshenker, MD RELEASE DATE: May 26, 2020 EXPIRATION DATE: May 31, 2021 TIME TO COMPLETE THE ACTIVITY: 1 hour TARGET AUDIENCEThis activity has been designed to meet the educational needs of physicians, advanced practice clinicians, nursing professionals, pharmacists, psychologists, social workers, rehabilitation specialists, researchers, advocates, and other members …

Progressive MS: Diagnosis, Clinical Course and Long-Term Management

Progressive MS: Diagnosis, Clinical Course and Long-Term ManagementPatricia K. Coyle, MD, FAAN, FANA RELEASE DATE: May 26, 2020 EXPIRATION DATE: May 31, 2021 TIME TO COMPLETE THE ACTIVITY: 1 hour TARGET AUDIENCEThis activity has been designed to meet the educational needs of physicians, advanced practice clinicians, nursing professionals, pharmacists, psychologists, social workers, rehabilitation specialists, researchers, …

John F. Kurtzke Lecture: Stem Cell Research Update

John F. Kurtzke Lecture: Stem Cell Research UpdateMark Freedman, MSc, MD, FRCPC RELEASE DATE: May 28, 2020 EXPIRATION DATE: May 31, 2021 TIME TO COMPLETE THE ACTIVITY: 1 hour TARGET AUDIENCEThis activity has been designed to meet the educational needs of physicians, advanced practice clinicians, nursing professionals, pharmacists, psychologists, social workers, rehabilitation specialists, researchers, advocates, …

MS Infusion Therapy Update with Q&A on COVID-19 Impact

RELEASED: March 23, 2020 EXPIRES: April 30, 2021 Faculty Carrie M. Hersh, DO, MScStaff NeurologistCleveland ClinicLou Ruvo Center forBrain HealthLas Vegas, NV Amy Perrin Ross,APN, MSN, CNRN, MSCNNeuroscience ProgramCoordinatorLoyola University Medical CenterMaywood, IL Why Attend? Treatment selection and modification in MS can be a complex, dauntingproblem for MS care providers. Enjoy active discussion with yourcolleagues …

Insights into the Management of Non-Active Progressive MS: Current and Future Perspectives

RELEASED: July 31, 2019 EXPIRES: July 31, 2020 This CE activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. Support for this activity has been provided through an educational grant from MedDay Pharmaceuticals. Credit Available Physicians — maximum of 1.5 AMA PRA Category 1 Credits™ Nurses — 1.5 contact hours (.5 in the area of …

IJMSC: Prevalence of Lower Urinary Tract Symptoms in People with MS: A Systematic Review and Meta-analysis

Release Date: April 1, 2020 Valid for Credit Through: April 1, 2021 Target Audience The target audience for this activity is physicians, physician assistants, nursing professionals, and other health care providers involved in the management of patients with multiple sclerosis (MS). Learning Objectives  Provide the pooled prevalence estimates of lower urinary tract symptoms (LUTSs) and …